ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DEAN TALLEY M.D.

Internal Medicine

34,107

$1.57M

850
580 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

AZHAR NISAR MD

Internal Medicine

30,538

$1.57M

544
317 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

44%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

POONAM SINGH MD

Internal Medicine

22,732

$1.57M

564
412 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $56

ROWLAND CHIGBU M.D.

Internal Medicine

2,822

$1.56M

225
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 26%

$552
Average prescription price

Avg: $56

ROBERT PUMPELLY MD

Internal Medicine

31,987

$1.56M

766
629 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

MARIA ACOSTA M.D.

Internal Medicine

32,645

$1.55M

1080
651 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

SUSAN HARDING MD

Internal Medicine

32,785

$1.54M

882
367 are 65+

21%
patients receiving schedule two controlled substances

Avg: 3%

57%
patients receiving schedule three controlled substances

Avg: 11%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

GANESH KINI MD

Internal Medicine

19,203

$1.53M

798
529 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$79
Average prescription price

Avg: $56

BRENT SAVELLI MD

Internal Medicine

29,156

$1.52M

984
664 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

CHRISTOPHER CROOKER M.D.

Internal Medicine

23,917

$1.52M

1344
1100 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $56

RACHEL NISBET M.D.

Internal Medicine

4,430

$1.51M

438
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 26%

$341
Average prescription price

Avg: $56

HARRISON CARTER MD

Internal Medicine

34,488

$1.51M

887
677 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

ANTHONY HOWARD M.D.

Internal Medicine

29,913

$1.48M

543
345 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

41%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

KAUSHIK AMIN MD

Internal Medicine

25,549

$1.48M

806
482 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $56

DAVID BOSSHARDT M.D.

Internal Medicine

28,597

$1.47M

1061
721 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

F. CONNER MD

Internal Medicine

24,632

$1.47M

819
647 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

BRYAN HOOKER MD

Internal Medicine

28,455

$1.47M

953
665 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

JAMES COCHRAN M.D.

Internal Medicine

40,327

$1.46M

1245
989 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$36
Average prescription price

Avg: $56

KEVIN NAPIER M.D.

Internal Medicine

28,350

$1.45M

1109
896 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

ANTHONY CAPTAIN M.D.

Internal Medicine

25,535

$1.45M

604
419 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

APPAVUCHETTY SOUNDAPPAN MD

Internal Medicine

30,170

$1.44M

620
478 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

STANLEY SMITH M.D.

Internal Medicine

29,858

$1.43M

1150
949 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

ARNOLD SMALLS MD

Internal Medicine

30,038

$1.41M

1219
825 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

CHARLES ROMAN D.O.

Internal Medicine

27,554

$1.4M

1300
844 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

BENJAMIN WILLIAMS MD

Internal Medicine

32,412

$1.35M

957
819 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank